Form 4: Madryn Entities Reallocate Neuronetics Shares

Madryn Asset Management's affiliated funds reallocated 337,312 Neuronetics common shares for internal fund administration purposes.

Summary

• Madryn Health Partners II, LP acquired 337,312 shares of Neuronetics, Inc. common stock.
• Madryn Health Partners II (Cayman Master), LP disposed of 337,312 shares of Neuronetics, Inc. common stock.
• The transactions occurred on July 10, 2025, and involved no monetary consideration.
• The transfer was conducted for internal fund administration purposes between affiliated entities.
• Following the transactions, Madryn Health Partners II, LP beneficially owns 1,430,953 shares, and Madryn Health Partners II (Cayman Master), LP beneficially owns 17,044,940 shares.
• Madryn Asset Management, LP serves as the investment advisor for both entities involved in the transfer.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event for Neuronetics, Inc., as it reflects an internal administrative adjustment by a major shareholder rather than a change in their overall investment position or a direct operational impact on the company.

Positives

• No direct positives for Neuronetics, Inc. as this is an internal administrative transaction by a 10% owner.

Negatives

• No direct negatives for Neuronetics, Inc. as this is an internal administrative transaction by a 10% owner.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that such internal reallocations among affiliated funds of a significant shareholder like Madryn Asset Management are common for portfolio management or administrative efficiency and typically do not signal a change in investment thesis regarding Neuronetics, Inc.

Related Party Transactions

• Transfer of 337,312 common shares between Madryn Health Partners II, LP and Madryn Health Partners II (Cayman Master), LP for fund administration purposes, with no consideration exchanged. Both entities are advised by Madryn Asset Management, LP.

Stakeholder Impact

• No direct impact on shareholders, employees, customers, suppliers, or creditors of Neuronetics, Inc. as this is an internal administrative transaction by a 10% owner.

Key Dates

Recommendation

The filing details an internal administrative transfer of shares between affiliated entities of a 10% owner. This transaction does not reflect a change in the overall investment position of the reporting group in Neuronetics, Inc., nor does it provide new information regarding the company's operational or financial performance. Therefore, it does not warrant a change in investment recommendation.

Keywords

Neuronetics, STIM, Madryn Asset Management, Form 4, Insider Transaction, Beneficial Ownership, Share Transfer, Fund Administration